Drugs / XTL6865
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00300807 | Oct 2005 → Apr 2007 | chronic hepatitis C virus infection | XTL Biopharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XTL6865 | “XTL6865, a mixture (1:1) of two human monoclonal antibodies (HCV-AbXTL68 and HCV-AbXTL65)” NCT00300807 ↗ |
| Modality | Monoclonal antibody | “XTL6865, a mixture (1:1) of two human monoclonal antibodies” NCT00300807 ↗ |